Melatonin Medice

Melatonin, the active ingredient in Melatonin Medice, is a melatonin receptor agonist presented as an unspecified strength/oral tablet for oral use. It is used to help regulate the sleep‑wake cycle and promote sleep onset in adults experiencing insomnia or circadian rhythm disturbances.

GNH USA supplies Melatonin Medice as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable sourcing for regulated markets. Manufactured under EU GMP guidelines, the product meets stringent safety and efficacy criteria.

Melatonin Medice acts on melatonin receptors to address sleep‑related disorders.

Insomnia: helps reduce sleep latency and increase total sleep time. Sleep‑wake rhythm disorders: assists in synchronising the circadian rhythm and stabilising sleep patterns. Delayed sleep phase syndrome: supports earlier sleep onset and improves daytime alertness.

Melatonin Medice may cause adverse reactions in some users.

Common Side Effects: - Headache - Dizziness - Nausea - Daytime sleepiness - Vivid dreams - Mild gastrointestinal discomfort

Serious or Rare Side Effects: - Allergic reactions such as rash or itching - Severe dizziness or vertigo - Mood changes including depression - Abnormal heart rhythm - Hallucinations or severe confusion - Marked hypotension

Before using Melatonin Medice, consider the following safety measures.

Assess sleep history: confirm the specific sleep disorder before initiation. Avoid driving after initial dose: possible residual drowsiness may impair performance. Use with caution in elderly: increased sensitivity to sedative effects. Review concomitant CNS depressants: risk of additive sedation. Pregnancy and lactation: consult a healthcare professional before use. Store at ambient temperature below 25°C: keep in the original container, protect from moisture and light.

Melatonin Medice can interact with other medicines; monitoring is advised.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may increase bleeding risk. - Immunosuppressants (e.g., cyclosporine): may reduce melatonin metabolism. - CNS depressants (e.g., benzodiazepines): additive sedation.

Moderate Interactions (Monitor Closely): - CYP1A2 inhibitors (e.g., fluvoxamine): may raise melatonin plasma levels. - CYP1A2 inducers (e.g., carbamazepine): may lower efficacy. - Oral contraceptives: may elevate melatonin concentrations.